Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PHADEZYM B2 MICRO TEST 100

K-Number: K830280 · 1983-03-25

Decision Date1983-03-25
Product Code
DecisionSubstantially Equivalent

Device Summary

PHADEZYM B2 MICRO TEST 100 is the device name listed in this FDA 510(k) record. The listed applicant is Pharmacia, Inc.. It received FDA 510(k) clearance on 1983-03-25 under 510(k) number K830280. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PHADEZYM B2 MICRO TEST 100?

PHADEZYM B2 MICRO TEST 100 is a medical device that received FDA 510(k) clearance on 1983-03-25. The listed applicant is Pharmacia, Inc.. The 510(k) number is K830280.

When did PHADEZYM B2 MICRO TEST 100 receive FDA 510(k) clearance?

PHADEZYM B2 MICRO TEST 100 received FDA 510(k) clearance on 1983-03-25, under 510(k) number K830280.

Who is the listed applicant for PHADEZYM B2 MICRO TEST 100?

The FDA 510(k) record lists Pharmacia, Inc. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Pharmacia, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 129 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑